Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
Why this paper is included
Supporting source evidence:
Of those subjects flagging a nutrition and supplement risk, 77.9% of subjects flagged the unhealthy diet risk behavior, 27.9% flagged >2 servings of fish, 25.2% flagged need omega-3 fatty acids, 62.5% flagged no folic acid supplement, 74.0% flagged no iron supplement, 62.1% flagged no calcium supplement, 50.0% flagged no vitamin D supplement, 19.2% flagged vitamin A supplement use, 61.0% flagged other supplement use, and 76.0% flagged caffeine.
Source: Preconception Risk Assessment. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Secondary analysis.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Meta-analysis unclear · Blinding unclear / not reported · Human research reported
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
We conducted a secondary analysis of data from a randomized controlled trial designed to study the impact of conversational agent technology in 13 domains of preconception care among 528 non-pregnant African American and Black women.
Source: Abstract.
Participants were recruited using research websites, community programs, and referrals.
Source: Methods.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Using Health Information Technology to Engage African American Women on Nutrition and Supplement Use During the Preconception Period
Secondary analysis · Frontiers in Endocrinology · 2021
Original publication title
Using Health Information Technology to Engage African American Women on Nutrition and Supplement Use During the Preconception Period
Copyright © 2021 Gardiner, Bickmore, Yinusa-Nyahkoon, Reichert, Julce, Sidduri, Martin-Howard, Woodhams, Aryan, Zhang, Fernandez, Loafman, Srinivasan, Cabral and Jack
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
Abstract: What methods does the paper describe?
We conducted a secondary analysis of data from a randomized controlled trial designed to study the impact of conversational agent technology in 13 domains of preconception care among 528 non-pregnant African American and Black women. This analysis is restricted to those 480 women who reported at least one of the ten risks related to nutrition and dietary supplement use.
Source: MethodsAbstract: Importance
Healthy nutrition and appropriate supplementation during preconception have important implications for the health of the mother and newborn. The best way to deliver preconception care to address health risks related to nutrition is unknown.
Source: ImportanceAbstract: Interventions
An online conversational agent, called “Gabby”, assesses health risks and delivers 12 months of tailored dialogue for over 100 preconception health risks, including ten nutrition and supplement risks, using behavioral change techniques like shared decision making and motivational interviewing. The control group received a letter listing their preconception risks and encouraging them to talk to a health care provider.
Source: InterventionsAbstract: Results
After 6 months, women using Gabby (a) reported progressing forward on the stage of change scale for, on average, 52.9% (SD, 35.1%) of nutrition and supplement risks compared to 42.9% (SD, 35.4) in the control group (IRR 1.22, 95% CI 1.03 to 1.45, P = 0.019); and (b) reported achieving the action and maintenance stage of change for, on average, 52.8% (SD 37.1) of the nutrition and supplement risks compared to 42.8% (SD, 37.9) in the control group (IRR 1.26, 96% CI 1.08 to 1.48, P = 0.004).
For subjects beginning the study at the contemplation stage of change, intervention subjects reported progressing forward on the stage of change scale for 75.0% (SD, 36.3%) of their health risks compared to 52.1% (SD, 47.1%) in the control group (P = 0.006).
Source: ResultsAbstract: Conclusion
The scalability of Gabby has the potential to improve women’s nutritional health as an adjunct to clinical care or at the population health level. Further studies are needed to determine if improving nutrition and supplement risks can impact clinical outcomes including optimization of weight.
Source: ConclusionAuthors’ abstract
Importance
Healthy nutrition and appropriate supplementation during preconception have important implications for the health of the mother and newborn. The best way to deliver preconception care to address health risks related to nutrition is unknown.
Methods
We conducted a secondary analysis of data from a randomized controlled trial designed to study the impact of conversational agent technology in 13 domains of preconception care among 528 non-pregnant African American and Black women. This analysis is restricted to those 480 women who reported at least one of the ten risks related to nutrition and dietary supplement use.
Interventions
An online conversational agent, called “Gabby”, assesses health risks and delivers 12 months of tailored dialogue for over 100 preconception health risks, including ten nutrition and supplement risks, using behavioral change techniques like shared decision making and motivational interviewing. The control group received a letter listing their preconception risks and encouraging them to talk to a health care provider.
Results
After 6 months, women using Gabby (a) reported progressing forward on the stage of change scale for, on average, 52.9% (SD, 35.1%) of nutrition and supplement risks compared to 42.9% (SD, 35.4) in the control group (IRR 1.22, 95% CI 1.03 to 1.45, P = 0.019); and (b) reported achieving the action and maintenance stage of change for, on average, 52.8% (SD 37.1) of the nutrition and supplement risks compared to 42.8% (SD, 37.9) in the control group (IRR 1.26, 96% CI 1.08 to 1.48, P = 0.004).
For subjects beginning the study at the contemplation stage of change, intervention subjects reported progressing forward on the stage of change scale for 75.0% (SD, 36.3%) of their health risks compared to 52.1% (SD, 47.1%) in the control group (P = 0.006).
Conclusion
The scalability of Gabby has the potential to improve women’s nutritional health as an adjunct to clinical care or at the population health level. Further studies are needed to determine if improving nutrition and supplement risks can impact clinical outcomes including optimization of weight.
Clinical Trial Registration
ClinicalTrials.gov, identifier NCT01827215.
Publication and source details
Original title: Using Health Information Technology to Engage African American Women on Nutrition and Supplement Use During the Preconception Period
Paula Gardiner; Timothy Bickmore; Leanne Yinusa-Nyahkoon; Matthew Reichert; Clevanne Julce; Nireesha Sidduri; Jessica Martin-Howard; Elisabeth Woodhams; Jumana Aryan; Zhe Zhang; Juan Fernandez; Mark Loafman; Jayakanth Srinivasan; Howard Cabral; Brian W. Jack
Frontiers in Endocrinology · 2021
Edited by: Qi Chen, The University of Auckland, New Zealand
Reviewed by: Yunhui Tang, Fudan University, China; Settimio D’Andrea, University of L’Aquila, Italy
This article was submitted to Reproduction, a section of the journal Frontiers in Endocrinology
Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-12T13:34:49.581141+00:00
DOI: 10.3389/fendo.2020.571705 · PMC7874041